Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Breast 1

Conditions

Carcinoma, Hepatocellular 16Cholangiocarcinoma 8Barrett Esophagus 6Thyroid Neoplasms 5Recurrence 5Pancreatic Neoplasms 5Liver Neoplasms 5Neoplasm Metastasis 4Lung Neoplasms 4Breast Neoplasms 4Thyroid Nodule 3Esophageal Neoplasms 3Colonic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Thyroid Diseases 2Thyroid Cancer, Papillary 2Prostatic Neoplasms 2Pain 2Neoplasms 2Hyperaldosteronism 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Agnosia 2Squamous Intraepithelial Lesions 1Rectal Neoplasms 1Papillary Thyroid Microcarcinoma 1Pancreatic cancer, adult 1Pancreatic Neuroendocrine Tumors, WHO Grade I-II 1Neuroma 1Neuralgia 1

Interventions

fludarabine phosphate 15Cyclophosphamide 15Peripheral Blood Stem Cell Transplantation 13Cyclosporine 12Whole-Body Irradiation 10Filgrastim 10Mycophenolic Acid 9Busulfan 8Antilymphocyte Serum 7Radiotherapy 5Methylprednisolone 5Melphalan 5Therapeutics 4Psychiatric Rehabilitation 4Methotrexate 4Exercise 4Etoposide 4Cord Blood Stem Cell Transplantation 4Blood Specimen Collection 4fludarabine 3Rituximab 3Prednisone 3Granulocyte Colony-Stimulating Factor 3Dexamethasone 3Aprepitant 3Analgesia 3plerixafor 2Tacrolimus 2Standard of Care 2Ondansetron 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Lymphoma, Follicular × Radiofrequency Ablation × Clear all
NCT07206121 2026-02-11

Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery

Innoblative Designs, Inc.

Phase NA Recruiting
10 enrolled
BreastLymphoid

Breast Neoplasms, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡